Ziwig Biotech Launches Groundbreaking Endometriosis Saliva Test – FINN Partners
FINN Partners shared a post on LinkedIn:
“Major announcement from FINN client Ziwig Biotech: Ziwig Endotest, the world’s first endometriosis saliva test, has received marketing authorization in the United States.
Endometriosis is a disease that affects 190 million women worldwide, nearly one in ten women of reproductive age. This news marks a major new step toward global access to endometriosis diagnosis.
Our recent Ziwig press conference showcased a remarkable journey, from a breakthrough innovation to a scientifically validated and globally deployed solution.
Key milestones achieved:
- Publication of the ENDOmiRNA study results in NEJM Evidence (Nov. 2025), the world’s first validation of a salivary biomarker for endometriosis
- Deployment of Ziwig Endotest in 37 countries
- ENDOBEST study: patient recruitment completed in France (2,500 patients), with a total of more than 25,000 women already benefiting from early access to the test in Ziwig’s country of origin
Research at the core of the vision. Beyond endometriosis, Ziwig is expanding its salivary RNA technology to other high–public health–impact conditions, including:
- multiple gynecological pathologies (the GYNARN study),
- ovarian cancer (the OVARN study),
- and ALS – Charcot disease (the SLARN study, inclusion completed).
Ziwig continues to show its unwavering commitment to transforming healthcare: precision, predictive, and accessible medicine is becoming a reality, powered by cutting-edge science, AI, and a patient-first global vision.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 14, 2026, 15:14This Month’s F and S On Air Podcast Is Out Now – Fertility and Sterility
-
Apr 14, 2026, 14:51Lydia Akpan: Key Signs of Oocyte Dysmorphism
-
Apr 14, 2026, 14:42Emre Göksan Pabuçcu: Honored to Speak at the 12th National Gynecological Endoscopy Congress
-
Apr 14, 2026, 14:36Shivam Rathore: Why Temperature and Humidity Control in IVF Labs is Non-Negotiable?
-
Apr 14, 2026, 14:29Yannick Hurni: Attending SEUD 2026 Has Been a Powerful Reminder of What Conferences Truly Represent
-
Apr 14, 2026, 14:26Maria Cristina Sangiovanni: Honored to Have Spoken at the 12th SEUD Congress in Frankfurt!
-
Apr 14, 2026, 14:21Nikolaos Polyzos: What Will Reproductive Medicine Look Like in 10 Years?
-
Apr 14, 2026, 14:16Xavier Carcopino: Early and Organized HPV Vaccination Saves Lives
-
Apr 14, 2026, 12:52Ting Yuan: Using Endometrial Immune Profiling in Young IVF Patients